A significant difference was also observed in the IL-17A, TNF-α, and INF-γ concentrations between the two groups of patients, with the MetS group showing significantly increased concentrations of these pro-inflammatory cytokines than the control group. This evidence concerns the gene IL17A and metabolic syndrome.